肺部醫療設備市場規模、佔有率和成長分析：按產品類型、適應症、器材便攜性、最終用戶、分銷管道和地區分類－2026年至2033年產業預測

2024 年全球呼吸醫療設備市場價值為 264.4 億美元，預計到 2033 年將從 2025 年的 279.7 億美元成長至 439 億美元，預測期（2026-2033 年）的複合年成長率為 5.8%。

全球呼吸設備市場的主要驅動力是慢性及急性呼吸系統疾病的日益普遍，這迫使醫療系統加強其診斷和治療能力。呼吸系統疾病的負擔導致高發病率和醫療成本增加，因此該市場涵蓋了人工呼吸器、氧氣濃縮機、霧化器和智慧吸入器等關鍵產品。尤其是在應對新冠疫情帶來的挑戰時，攜帶式、方便用戶使用型設備和先進的整合軟體的需求顯著成長。連接性、分析和遠端醫療技術的整合進一步加速了市場成長，使臨床醫生能夠進行持續監測和早期療育。此外，人工智慧在診斷工具中的應用，透過增強影像分析和工作流程整合，提高了診斷準確性，簡化了流程，並促進了其在臨床環境中的更廣泛應用。

全球呼吸醫療設備市場的成長要素

慢性及急性呼吸系統疾病發生率的上升顯著增加了對用於診斷、監測和治療的呼吸系統醫療設備的需求。醫療專業人員積極尋求更有效的工具，以實現對這些疾病的早期發現和有效的長期管理。這一趨勢促使臨床醫生廣泛採用各種醫療設備，從而能夠在包括醫院和居家照護環境在內的不同場所製定個人化治療方案並改善呼吸系統健康。為此，製造商致力於改進和推廣創新產品，而保險公司和醫療服務提供者也擴大將醫療設備介入納入日常護理，進一步推動了市場成長。

全球肺部疾病醫療設備市場面臨的限制因素

全球呼吸設備市場面臨許多挑戰，其中包括先進呼吸技術高昂的部署和維修成本對醫療機構帶來的財務壓力。這往往限制了這些技術的應用，只有資金雄厚的醫療機構才能採用，阻礙了市場滲透。保險公司通常不願意為使用新型醫療設備的治療方法買單，除非其價值得到充分證明，導致醫院傾向於選擇成熟的低成本方案。此外，新興市場對成本的敏感度加劇了這些挑戰，使得小規模診所和居家醫療機構推遲對新技術的投資。這些財務障礙最終延緩了創新呼吸解決方案在常規臨床實踐中的應用，限制了市場成長。

全球呼吸設備市場趨勢

全球呼吸設備市場正日益向分散式醫療模式轉型，強調遠距醫療和居家照護解決方案。這項轉變優先發展具有使用者友善介面和互通平台的攜帶式設備，從而提高患者依從性，並促進醫療專業人員在傳統醫院環境之外進行持續監測。與遠端醫療提供者和護理網路建立策略合作夥伴關係對於將慢性呼吸系統疾病的管理延伸至整個護理流程至關重要。製造商正致力於提升患者教育水平、簡化設備操作、增強數據無縫共用能力，以增強患者的長期參與度並實現及時干預，從而使其產品適應不斷變化的門診護理環境和以結果為導向的指標。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球肺部醫療設備市場規模：依產品類型分類

• 治療設備
  • 人工呼吸器和人工呼吸器
  • 霧化器和吸入器
• 診斷和監測設備
  • 肺計量計
  • 脈搏血氧飽和度分析儀
• 外科手術及介入器械
• 其他

全球肺部醫療設備市場規模：依適應症分類

• 慢性阻塞性肺病
• 氣喘
• 睡眠呼吸中止症和睡眠障礙
• 肺癌和呼吸道感染疾病
• 其他

全球肺部醫療設備市場規模：器材便攜性

• 固定式及桌上型設備
• 可攜式和手持式設備
• 穿戴式監測單元
• 其他

全球肺部醫療設備市場規模：依最終用戶分類

• 醫院和專科診所
• 居家醫療和個別患者
• 門診手術中心
• 其他

全球肺部醫療設備市場規模：按分銷管道分類

• 直接向醫療機構銷售
• 零售藥局和醫療用品店
• 網路醫療市場
• 其他

全球肺部醫療設備市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic
• Philips Healthcare
• ResMed
• Fisher & Paykel Healthcare
• Drager
• Getinge
• Becton Dickinson（BD）
• Teleflex
• ICU Medical（Smiths Medical）
• Vyaire Medical
• Masimo
• Nihon Kohden
• Hamilton Medical
• Invacare
• Inogen
• Air Liquide Medical Systems
• Zoll Medical
• Apex Medical
• Lowenstein Medical
• Mindray

結論與建議

Global Pulmonary Devices Market size was valued at USD 26.44 Billion in 2024 and is poised to grow from USD 27.97 Billion in 2025 to USD 43.9 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The global pulmonary devices market is significantly driven by the increasing prevalence of chronic and acute respiratory diseases, prompting health systems to enhance their diagnostic and therapeutic capabilities. This market includes essential products such as ventilators, oxygen concentrators, nebulizers, and smart inhalers, as the burden of respiratory illnesses contributes to high morbidity and healthcare costs. A notable trend is the shift towards portable, user-friendly devices and advanced integrated software, particularly following challenges highlighted by the pandemic. The integration of connectivity, analytics, and telehealth technologies has further propelled market growth, allowing for continuous monitoring and early intervention by clinicians. Additionally, the incorporation of AI into diagnostic tools enhances accuracy through improved image analysis and workflow integration, streamlining processes and fostering broader adoption in clinical settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pulmonary Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pulmonary Devices Market Segments Analysis

Global pulmonary devices market is segmented by product type, indication, device portability, end-user, distribution channel and region. Based on product type, the market is segmented into Therapeutic Devices, Diagnostic and Monitoring Devices, Surgical and Interventional Devices and Others. Based on indication, the market is segmented into Chronic Obstructive Pulmonary Disease, Asthma, Sleep Apnea and Sleep Disorders, Lung Cancer and Respiratory Infections and Others. Based on device portability, the market is segmented into Stationary and Benchtop Devices, Portable and Handheld Devices, Wearable Monitoring Units and Others. Based on end-user, the market is segmented into Hospitals and Specialty Clinics, Homecare and Individual Patients, Ambulatory Surgical Centers and Others. Based on distribution channel, the market is segmented into Direct Sales to Healthcare Institutions, Retail Pharmacies and Medical Supply Stores, Online Healthcare Marketplaces and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pulmonary Devices Market

The rising incidence of both chronic and acute respiratory illnesses is driving significant demand for pulmonary devices used in diagnosis, monitoring, and treatment. Healthcare professionals are actively searching for enhanced tools that facilitate early detection and effective long-term management of these conditions. This trend leads to a broader implementation of various devices among clinicians, enabling them to customize treatment plans and improve patient respiratory health in diverse environments, including hospitals and home care settings. In response, manufacturers are focusing on advancing and distributing innovative products, while insurers and healthcare providers increasingly embrace device-based interventions as part of routine care, fueling further market growth.

Restraints in the Global Pulmonary Devices Market

The Global Pulmonary Devices market faces significant restraints due to the high acquisition and maintenance costs associated with advanced pulmonary technologies, which create financial limitations for healthcare providers. This often leads to procurement being confined to well-funded institutions, thereby hindering broader adoption. Insurance payers may hesitate to cover newer device-based interventions unless their value is clearly established, pushing hospitals to focus on established, lower-cost options. Furthermore, cost sensitivity in emerging markets exacerbates these challenges, causing smaller clinics and home care agencies to postpone investments in new technologies. Such financial barriers ultimately slow the integration of innovative pulmonary solutions into everyday clinical practice, limiting market growth.

Market Trends of the Global Pulmonary Devices Market

The Global Pulmonary Devices market is increasingly leaning towards decentralized healthcare models, emphasizing remote and home-based care solutions. This shift prioritizes the development of portable devices equipped with user-friendly interfaces and interoperable platforms, facilitating effective patient adherence and continuous clinician monitoring beyond traditional hospital settings. Strategic collaborations with telehealth providers and care networks are becoming vital for extending management of chronic respiratory diseases throughout the entire care continuum. By focusing on patient education, device usability, and seamless data-sharing capabilities, manufacturers aim to enhance long-term engagement and enable timely interventions, aligning their products with the evolving outpatient care landscape and outcome-driven metrics.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Pulmonary Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Therapeutic Devices
  • Ventilators and Resuscitators
  • Nebulizers and Inhalers
• Diagnostic and Monitoring Devices
  • Spirometers
  • Pulse Oximeters
• Surgical and Interventional Devices
• Others

Global Pulmonary Devices Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Chronic Obstructive Pulmonary Disease
• Asthma
• Sleep Apnea and Sleep Disorders
• Lung Cancer and Respiratory Infections
• Others

Global Pulmonary Devices Market Size by Device Portability & CAGR (2026-2033)

• Market Overview
• Stationary and Benchtop Devices
• Portable and Handheld Devices
• Wearable Monitoring Units
• Others

Global Pulmonary Devices Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals and Specialty Clinics
• Homecare and Individual Patients
• Ambulatory Surgical Centers
• Others

Global Pulmonary Devices Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales to Healthcare Institutions
• Retail Pharmacies and Medical Supply Stores
• Online Healthcare Marketplaces
• Others

Global Pulmonary Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Indication, Device Portability, End-User, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Indication, Device Portability, End-User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Indication, Device Portability, End-User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Indication, Device Portability, End-User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Indication, Device Portability, End-User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ResMed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fisher & Paykel Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drager
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical (Smiths Medical)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vyaire Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invacare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inogen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Air Liquide Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoll Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apex Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lowenstein Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations